CLINICAL_TRIALS
research
· 2025-08-13
Clinical Trial Update: Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.
Summary
This multicenter retrospective study evaluates the incidence of breast cancer in adult female Hodgkin lymphoma survivors treated with MBVD (including non-pegyla…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Federico II University | Conditions: Hodgkin Disease, Breast Cancer | Status: COMPLETED